Elisha M Wachman, MD

Opioid use has quadrupled in pregnancy, but effective medication options remain elusive for pregnant and breastfeeding persons.

BMC experts testified in support of eliminating the requirement to report abuse and neglect for babies born with neonatal opioid withdrawal syndrome.

A less than 5% transmission rate in newborns suggests the placenta has properties that prevent COVID-19 infection.

The first multi-site study of the ESC model suggests a nonpharmacologic care model focused on maternal engagement is a safe option for widespread use.

New findings suggest that the understudied medication may lead to better short-term outcomes for some pregnant women with OUD and their babies.

Study comparing two models of care shows benefits of symptom-triggered dosing over a fixed medication schedule.